Index Pharmaceuticals Holding Stock: price and insider trades · Sweden

Index Pharmaceuticals Holding is a listed company. Filings by its managers are published through Finansinspektionen. 3 insiders have disclosed 5 filings since 23 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 5 purchases totalling €59k, made by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €14k, the purchase published on 28 April 2026 by Mark Quick is the largest of the period. Among those who bought: 1 board member, 1 finance chief and 1 chief executive.

For context, the typical company on the same exchange (median of 1,027 companies) published 9 filings over the same period, against 5 filings here. Looking back to 2017, when coverage begins, insiders filed 25 purchases and 15 sales.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 21 October 2026, 18 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades.

Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.